MRI characteristics and scoring in HDLS due to CSF1R gene mutations

Neurology

Volumn 79, Issue 6, 2012, Pages 566-574

  Sundal, Christina ^a,c   Van Gerpen, Jay A ^a   Nicholson, Alexandra M ^b   Wider, Christian ^a   Shuster, Elizabeth A ^a   Aasly, Jan ^d   Spina, Salvatore ^e   Ghetti, Bernardino ^e   Roeber, Sigrun ^f   Garbern, James ^k   Borjesson Hanson, Anne ^c   Tselis, Alex ^g   Swerdlow, Russell H ^h   Miller, Bradley B ⁱ   Fujioka, Shinsuke ^a   Heckman, Michael G ^a   Uitti, Ryan J ^a   Josephs, Keith A ^j   Baker, Matt ^b   Andersen, Oluf ^c   Rademakers, Rosa ^b   Dickson, Dennis W ^b   Broderick, Daniel ^a   Wszolek, Zbigniew K ^a   more..

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MUNICH   (Germany)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

ⁱ TEXAS TECH UNIVERSITY   (United States)

^j MAYO CLINIC   (United States)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR 1 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOPSY; BRAIN ATROPHY; BRAIN BIOPSY; CHROMOSOME 5; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE MUTATION; GRAY MATTER; HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY WITH SPHEROID; HETEROZYGOTE; HUMAN; LEUKOENCEPHALOPATHY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYRAMIDAL TRACT; SCORING SYSTEM; WHITE MATTER LESION;

EID: 84866127047     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318263575a     Document Type: Article

References (39)

1. van der Knaap M, Valk J, Barkhof F, eds. Magnetic Resonance of Myelination and Myelin Disorders, 3rd ed. New York: Birkhaüser; 2005.
2. Schiffmann R, van der Knaap MS. Invited article: an MRIbased approach to the diagnosis of white matter disorders. Neurology 2009;72:750 -759.
3. Axelsson R, Roytta M, Sourander P, Akesson HO, Andersen O. Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr Scand Suppl 1984;314:1- 65.
4. Rademakers R, Baker M, Nicholson AN, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) cause hereditary diffuse leukoencephalopathy with spheroids Nature Genetics 2011;44:200 -205.
5. Sundal C, Lash J, Aasly J, et al. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci 2012;314:130 -137.
6. Salonen O, Autti T, Raininko R, Ylikoski A, Erkinjuntti T. MRI of the brain in neurologically healthy middle-aged and elderly individuals. Neuroradiology 1997;39:537-545.
7. Raininko R, Autti T, Vanhanen SL, Ylikoski A, Erkinjuntti T, Santavuori P. The normal brain stem from infancy to old age: a morphometric MRI study. Neuroradiology 1994;36: 364-368.
8. Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996;36:268 -272.
9. Loes DJ, Hite S, Moser H, et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994;15:1761-1766.
10. Loes DJ, Peters C, Krivit W. Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. AJNR Am J Neuroradiol 1999;20:316 -323.
11. Eichler F, Grodd W, Grant E, et al. Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am J Neuroradiol 2009;30:1893-1897.
12. Baba Y, Ghetti B, Baker MC, et al. Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol 2006; 111:300 -311.
13. Yamashita M, Yamamoto T. Neuroaxonal leukoencephalopathy with axonal spheroids. Eur Neurol 2002;48: 20 -25.
14. Itoh K, Shiga K, Shimizu K, Muranishi M, Nakagawa M, Fushiki S. Autosomal dominant leukodystrophy with axonal spheroids and pigmented glia: clinical and neuropathological characteristics. Acta Neuropathol 2006;111: 39-45.
15. Mendes A, Pinto M, Vieira S, Castro L, Carpenter S. Adult-onset leukodystrophy with axonal spheroids. J Neurol Sci 2010;297:40-45.
16. Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 2008;71:925-929.
17. Hancock N, Poon M, Taylor B, McLean C. Hereditary diffuse leucoencephalopathy with spheroids. J Neurol Neurosurg Psychiatry 2003;74:1345-1347.
18. Browne L, Sweeney BJ, Farrell MA. Late-onset neuroaxonal leucoencephalopathy with spheroids and vascular amyloid. Eur Neurol 2003;50:85-90.
19. Moro-de-Casillas ML, Cohen ML, Riley DE. Leucoencephalopathy with neuroaxonal spheroids (LENAS) presenting as the cerebellar subtype of multiple system atrophy. J Neurol Neurosurg Psychiatry 2004;75:1070-1072.
20. Terada S, Ishizu H, Yokota O, et al. An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer's disease. Acta Neuropathol 2004;108:538 -545.
21. Mayer B, Oelschlaeger C, Keyvani K, Niederstadt T. Two cases of LENAS: diagnosis by MRI and biopsy. J Neurol 2007;254:1453-1454.
22. Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology 2008;70:1128 -1133.
23. Mateen FJ, Keegan BM, Krecke K, Parisi JE, Trenerry MR, Pittock SJ. Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. J Neurol Neurosurg Psychiatry 2010;81:619-622.
24. Boisse L, Islam O, Woulfe J, Ludwin SK, Brunet DG. Neurological picture: hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: novel imaging findings. J Neurol Neurosurg Psychiatry 2010;81:313-314.
25. van der Knaap MS, Naidu S, Kleinschmidt-Demasters BK, Kamphorst W, Weinstein HC. Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology 2000;54:463- 468.
26. Freeman SH, Hyman BT, Sims KB, et al. Adult onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations. Brain Pathol 2009;19:39-47.
27. Wider C, Van Gerpen JA, DeArmond S, Shuster EA, Dickson DW, Wszolek ZK. Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology 2009;72:1953-1959.
28. Maillart E, Rousseau A, Galanaud D, et al. Rapid onset frontal leukodystrophy with decreased diffusion coefficient and neuroaxonal spheroids. J Neurol 2009;256:1649 - 1654.
29. Sundal C, Ekholm S, Nordborg C, et al. Update of the original HDLS kindred: divergent clinical courses. Acta Neurol Scand 2012;126:67-75.
30. Sundal C, Ekholm S, Andersen O. White matter disorders with autosomal dominant heredity: a review with personal clinical case studies and their MRI findings. Acta Neurol Scand 2010;121:328 -337.
31. Patel B, Markus HS. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke 2011;6:47-59.
32. Palmer S, Bradley WG, Chen DY, Patel S. Subcallosal striations: early findings of multiple sclerosis on sagittal, thinsection, fast FLAIR MR images. Radiology 1999;210: 149-153.
33. Saenz R, Quan AW, Magalhaes A, Kish K. MRI of Susac's syndrome. AJR Am J Roentgenol 2005;184:1688 -1690.
34. Charil A, Dagher A, Lerch JP, Zijdenbos AP, Worsley KJ, Evans AC. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage 2007;34: 509-517.
35. Schirmer L, Antel JP, Bruck W, Stadelmann C. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathol 2011;21:428-440.
36. Ryberg C, Rostrup E, Sjostrand K, et al. White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am J Neuroradiol 2008; 29:1498 -1504.
37. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000;123:1845-1849.
38. Di Paola M, Luders E, Di Iulio F, et al. Callosal atrophy in mild cognitive impairment and Alzheimer's disease: different effects in different stages. Neuroimage 2010;49:141-149.
39. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841- 851.